- Home
- JVA vs IGC Comparison
JVA vs IGC Comparison
Compare JVA & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- IGC
- Stock Information
- Founded
- JVA 1971
- IGC 2005
- Country
- JVA United States
- IGC United States
- Employees
- JVA N/A
- IGC N/A
- Industry
- JVA Packaged Foods
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- JVA Consumer Staples
- IGC Health Care
- Exchange
- JVA Nasdaq
- IGC Nasdaq
- Market Cap
- JVA 24.7M
- IGC 20.2M
- IPO Year
- JVA 2005
- IGC N/A
- Fundamental
- Price
- JVA $4.50
- IGC $0.38
- Analyst Decision
- JVA
- IGC Strong Buy
- Analyst Count
- JVA 0
- IGC 2
- Target Price
- JVA N/A
- IGC $3.88
- AVG Volume (30 Days)
- JVA 227.0K
- IGC 6.7M
- Earning Date
- JVA 06-13-2025
- IGC 08-07-2025
- Dividend Yield
- JVA N/A
- IGC N/A
- EPS Growth
- JVA 856.08
- IGC N/A
- EPS
- JVA 0.65
- IGC N/A
- Revenue
- JVA $84,651,329.00
- IGC $1,271,000.00
- Revenue This Year
- JVA N/A
- IGC $15.26
- Revenue Next Year
- JVA N/A
- IGC $3.41
- P/E Ratio
- JVA $6.97
- IGC N/A
- Revenue Growth
- JVA 15.86
- IGC N/A
- 52 Week Low
- JVA $1.50
- IGC $0.25
- 52 Week High
- JVA $9.93
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- JVA 57.42
- IGC 65.10
- Support Level
- JVA $4.15
- IGC $0.30
- Resistance Level
- JVA $4.54
- IGC $0.46
- Average True Range (ATR)
- JVA 0.28
- IGC 0.02
- MACD
- JVA -0.01
- IGC 0.01
- Stochastic Oscillator
- JVA 61.54
- IGC 48.81
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.